Acandis Gmbh
Clinical trials sponsored by Acandis Gmbh, explained in plain language.
-
New stent trial aims to stop second strokes in Hard-to-Treat carotid disease
Disease control Recruiting nowThis study compares a stent (CARESTO® heal) plus standard medication against medication alone in 536 people who recently had a stroke or retinal artery blockage due to a specific type of carotid artery disease that is not severely narrowed. The goal is to see if the stent can low…
Sponsor: Acandis GmbH • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New stent aims to seal brain aneurysms safely
Disease control Recruiting nowThis study tests a device called DERIVO 2heal, a small mesh tube placed in an artery to block blood flow into a brain aneurysm. The goal is to see if it safely and effectively seals the aneurysm over the medium and long term. About 158 adults with brain aneurysms will be enrolled…
Sponsor: Acandis GmbH • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC
-
Stent could silence ringing in the ear
Symptom relief Recruiting nowThis study tests a stent called SiREX to treat pulsatile tinnitus—a rhythmic ringing in the ear—caused by a narrowed vein in the brain. About 78 adults with symptoms lasting over three months will receive the stent. The main goal is to see if the tinnitus disappears 90 days after…
Phase: NA • Sponsor: Acandis GmbH • Aim: Symptom relief
Last updated Jun 26, 2026 13:25 UTC